Central Corporation | Cuidado de la Piel / Productos Cuasi-farmacéuticosOEM Manufacturing (Okayama)

Acerca de la Fabricación OEM de Central Corporation

A cosmetics manufacturing and research company established in 1980, offering ultra-small-lot OEM production starting from just 100 units. Creates original brands with custom blending from scratch—cleansers and toners from 60,000 yen, serums and creams from 80,000 yen. Maintains advanced raw materials including umbilical cord blood exosomes and stem cell culture extracts.

Actividades Empresariales de Central Corporation

• Central Corporation (株式会社セントラル・コーポレーション) operates primarily in small-batch cosmetics OEM manufacturing under the concept of "Launch products with orders as small as 100 units." The company also engages in test marketing services and research and development of cosmetic raw materials. Specializing in basic skincare and anti-aging cosmetics
• Central Corporation is actively involved in the development of advanced raw materials including growth factors
• stem cell culture media
• and exosomes.

Características y Fortalezas de Central Corporation

• Ultra-small lot production from 100 units
• proprietary advanced ingredients (stem cells
• exosomes)
• brand launch support from low price points

Información de Fabricación de Central Corporation

Especialidades de Central Corporation

• Skincare
• anti-aging care
• serums

Certificaciones y Equipamiento de Central Corporation

Equipamiento Principal

• Emulsification equipment
• filling equipment
• quality inspection equipment

Logros de Central Corporation

Ubicaciones de Central Corporation

Historia de la Empresa Central Corporation

• —

  Central Corporation was established in September 1980. In 1985, the company pioneered the industry's first small-batch manufacturing system capable of producing 100 units. The ES301 Series was launched in 1987. In 2001, R-Cell Research Institute (Micromolecule Extraction Research Institute) was established in Miyazaki Prefecture. The company completed its nanonization double liposome encapsulation technology in 2008. In 2020, it began importing umbilical cord blood stem cell culture media raw materials, and in 2022, successfully developed domestically-produced stem cell culture media raw materials.

Premios y Reconocimientos de Central Corporation

• Social and Cultural Achievement Award (Presented on December 5
• 2011
• by His Imperial Highness Fushimi Hiraki of the former imperial family at Hakuplatai Hassoen in recognition of achievements in small-batch manufacturing)

Categorías Soportadas por Central Corporation

Preguntas Frecuentes sobre Central Corporation